GGrantIndex
Sort

23,748 grants matching melanoma

Administrative Core

$174,483
Eva Hernando · New York University School Of Medicine · U54 · FY2023 · CA

Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF

$174,462
Dario Marchetti · University Of New Mexico Health Scis Ctr · R01 · FY2021 · CA

Poly (amino acid) as an Integrin Targeted Drug Carrier

$174,418
University Of The Pacific-Stockton · R15 · FY2005 · CA

Role of cDC2 subsets in host protection and CD4T cell responses in melanoma

$174,406
Yosuke Kumamoto · Rbhs-New Jersey Medical School · R21 · FY2022 · CA

Tissue and Research Pathology Services

$174,350
Rajiv Dhir · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA

Cell Biology Core

$174,287
Meenhard Herlyn · Wistar Institute · P01 · FY2011 · CA

Increasing the Potency of CD-34-DC Vaccines

$174,284
Jacques F Banchereau · Baylor Research Institute · P01 · FY2008 · CA

Mechanisms of autoimmune thyroid disease and the role of interferon-alpha

$174,232
Jennifer Sophie Mammen · Johns Hopkins University · K23 · FY2015 · DK

Nanostructured Cancer Vaccines

$174,162
T. Andrew Taton · University Of Minnesota · R01 · FY2010 · CA

A novel gene-based immunotherapy inducing melanoma destruction

$174,151
Katja Michael · University Of Texas El Paso · R21 · FY2024 · CA

Targeting an MT1-MMP/MMP2 axis in melanoma by a novel MT1-MMP/MMP2 inhibitor

$174,147
Barbara Bedogni · Case Western Reserve University · R21 · FY2016 · CA

Population Research Core

$174,118
Myles G Cockburn · University Of Southern California · P30 · FY2023 · CA

Cell Culture Core

$174,034
Ruth Halaban · Yale University · P30 · FY2007 · AR

Biostatistics Core

$174,019
Phyllis A Gimotty · Wistar Institute · P01 · FY2011 · CA

Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade

$174,000
Sapna Patel · University Of Tx Md Anderson Can Ctr · R21 · FY2017 · CA

Functional Attributes of a CD8+BTLA+ T cell subset in Adoptive T Cell Therapy

$174,000
Laszlo George Radvanyi · University Of Tx Md Anderson Can Ctr · R21 · FY2013 · CA

Mutation Profile as Translatable Prognostic Biomarker of Uveal Melanoma

$174,000
Arupa Ganguly · University Of Pennsylvania · R21 · FY2016 · CA

In situ assay imaging nuclear RNA exosome activity for cancer studies

$174,000
Vladimir V Didenko · Baylor College Of Medicine · R21 · FY2021 · CA

Strategies to Enhance Post-Transplant Tumor Vaccination

$173,940
Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Higher-order chromatin remodeling and regulation of pigmentation

$173,931
Andrey Sharov · Boston University Medical Campus · R21 · FY2014 · AR

Role of probiotic Lactobacillus reuteri in orchestrating systemic anti-tumor immunity

$173,867
Marlies Meisel · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · CA

Leveraging MR-Guided Focused Ultrasound to Potentiate Immunotherapy for GBM

$173,754
Timothy N Bullock · University Of Virginia · R21 · FY2019 · CA

PSMA-Dye Surgical Margin Imaging During Prostatectomy

$173,741
Spectros Corporation · R44 · FY2004 · CA

Mechanisms of autoimmune thyroid disease and the role of interferon-alpha

$173,722
Jennifer Sophie Mammen · Johns Hopkins University · K23 · FY2016 · DK

Protein-Protein Interactions in Melanosome Biogenesis

$173,654
Wake Forest University Health Sciences · R01 · FY2004 · AR